Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dumitru

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Journal of Translational Medicine|October 6, 2011
EGFR-specific T cell frequencies correlate with EGFR expression in head and neck squamous cell carcinomaPatrick J Schuler, Petra Boeckers, Rainer Engers, et al.
Frontiers in Pharmacology|October 10, 2024
Muscarinic receptor drug trihexyphenidyl can alter growth of mesenchymal glioblastoma <i>in vivo</i>Renfei Du, Ahmed Y Sanin, Wenjie Shi, et al.
Acta Neuropathologica|October 15, 2017
Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesisUlrike Beyer, Frank Brand, Helge Martens, et al.
Scientific Reports|December 5, 2025
Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in Parkinson's disease: a randomized double-blind prospective studyTobias Hegelmaier, Alexander Duscha, Christiane Desel, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Journal of Translational Medicine|October 6, 2011
EGFR-specific T cell frequencies correlate with EGFR expression in head and neck squamous cell carcinomaPatrick J Schuler, Petra Boeckers, Rainer Engers, et al.
Frontiers in Pharmacology|October 10, 2024
Muscarinic receptor drug trihexyphenidyl can alter growth of mesenchymal glioblastoma <i>in vivo</i>Renfei Du, Ahmed Y Sanin, Wenjie Shi, et al.
Acta Neuropathologica|October 15, 2017
Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesisUlrike Beyer, Frank Brand, Helge Martens, et al.
Scientific Reports|December 5, 2025
Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in Parkinson's disease: a randomized double-blind prospective studyTobias Hegelmaier, Alexander Duscha, Christiane Desel, et al.
Pageof 7